Clinical trial
Evaluation of Atazanavir Substitution Intervention (EASI) Study
NCT00247845 · University of British Columbia, Other · Completed
Key facts
| NCT number | NCT00247845 |
|---|---|
| Title | Evaluation of Atazanavir Substitution Intervention (EASI) Study |
| Official title | Evaluation of Atazanavir Substitution Intervention (EASI) Study: An Observational Phase IV Study to Evaluate the Impact of Atazanavir Substitution on the Quality of Life and Maintenance of Virologic Suppression in HIV-Infected Patients Intolerant to Current Successful HAART |
| Lead sponsor | University of British Columbia, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | HIV Infections |
| Enrollment | 100 |
| Start date | Jul 1, 2004 |
| Completion | Sep 1, 2007 |
| First posted | Nov 2, 2005 |
| Last update posted | Aug 22, 2014 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: